Document is current
Any future updates will be listed below
-
Authors
Ruta, Giulia Vittoria
Ciciani, Matteo
Kheir, Eyemen
Gentile, Michele Domenico
Amistadi, Simone
Casini, Antonio
Cereseto, Anna http://orcid.org/0000-0003-4453-2597
-
Funding
Funding for this research was provided by:
Horizon 2020 (825825)
HORIZON EUROPE European Innovation Council (01071041)
- License Information
-
More Information
Article History
Received: 26 September 2023
Accepted: 13 March 2024
First Online: 25 March 2024
Declarations
:
: Not applicable.
: Not applicable.
: The authors declare competing financial interests: A.Ce. is a co-founder and holds shares of Alia Therapeutics, a genome editing company. A.Ca. is a co-founder, holds shares, and is currently an employee of Alia Therapeutics. M.C. is a consultant of Alia Therapeutics.
